title: The JAK2V617F mutation: no impact on circulating hematopoietic progenitors in myeloproliferative disorders.
authors.forename: Michaela
authors.initials: M
authors.lastname: Wappl
authors.forename: Eva
authors.initials: E
authors.lastname: Jaeger
authors.forename: Raiko
authors.initials: R
authors.lastname: Kusec
authors.forename: Ilse
authors.initials: I
authors.lastname: Schwarzinger
authors.forename: Klaus
authors.initials: K
authors.lastname: Geissler
authors.forename: Leopold
authors.initials: L
authors.lastname: Oehler
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000201:enzymology / Q000235:genetics* / Q000401:mortality; D012016:Reference Values; D015996:Survival Rate
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2